+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Mobile Apps for DNA Sequencing: Global Markets

  • ID: 4466406
  • Report
  • February 2018
  • Region: Global
  • 192 pages
  • BCC Research
1 of 5


  • 23Andme
  • Exploragen
  • Helix
  • Illumina
  • Oxford Nanopore
  • Qiagen
  • MORE
Report Scope:

This report is a comprehensive business tool, designed to provide an in-depth look at mobile applications of DNA sequencing. The geographical scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector and its participants and trends for the future.

Areas discussed include current funding being provided by the National Institutes of Health (NIH) in the U.S. and the National Health Service (NHS) in the U.K., which are at the forefront of this developing market. Funding worldwide is discussed in this report, together with the thought processes behind applying precision medicine to healthcare services.

Clinical trials are discussed in the report, together with developing technologies, software and cloud data storage, which are driving the translational science market for future precision medicine healthcare.

Categories discussed in the report include applications of:
  • DNA sequencing/mapping.
  • Genome sequencing/mapping.
  • Gene sequencing/mapping.
  • Exome sequencing.
  • Metagenomics.
  • Targeted sequencing.
Devices for individual use, which in the main use Android or iOS operating systems, are discussed briefly. While the device market is not specifically part of this report, the developing technology will be used for the future of this market, including:
  • iPads.
  • PCs.
The end-use segments discussed in the report are:
  • Genealogy.
  • Computational biology/rare diseases.
Categories, platform segments and regions are discussed in detail, including describing and identifying current products on the market, measuring the market size, and market drivers with a forecast to 2022.

Competitors are assessed, together with their respective market shares. For the country-level breakdown of segments, only the base year 2017 and projections to 2022 are indicated in the data in the tables. Year-to-year differences are considered as statistically insignificant.

The market evaluation in the study pertains to existing processes and/or devices used in the mobile application of DNA sequencing, and which have been developed and approved for human clinical use. The market size takes this into account. Options/upgrades or refurbished/remarketed equipment has not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services also related to the application of DNA sequencing conditions are discussed. Metrics countrywide, using information at the country level to look at the dynamics and their impact on reviews and growth, are used. Interviews were used to confirm and/or adjust the U.S. market size and market share estimates, as well as formulating market projections.

This report concentrates on the processes behind DNA sequencing techniques and discusses the developers of DNA sequencing and mobile applications of DNA sequencing and the history, processes and future developments being used to create and develop mobile applications.

Included in the report is a general overview of the genetic processes and terms used in the main areas of genomic studies and preparations. The report provides an outline only of the main areas involved with DNA sequencing.

This is a new market moving forward into revolutionary global healthcare through precision medicine. This report therefore reflects the new apps that have just become available in the market, together with developing technology. Clinical trials pertaining to moving toward the new global healthcare of precision medicine is studied in this report.

Included in the report is the developing market in the bioinformatics field of genetics and translational medicine from current standard medical practices to medical practices involving computational biology. Some devices studied in the report touch on the current and future market. The devices forecasted in the report are those that pertain to the current developing mobile apps market.

Specifically excluded from the study, as it is considered beyond the scope of the report, is an in-depth study of individuals who have had their DNA sequenced or mapped. Also excluded from the report is a detailed, in-depth study of the types of technology and methodology and terminology used, although this is outlined in general. Also excluded from the report is a detailed study of all the processes involved in genetics/genomes/sequencing as this topic is too vast in itself to explore in this report.

Also excluded from the report is a detailed description of all types of DNA sequencing, although the main areas in this topic are discussed, a further detailed in-depth examination of DNA sequencing is not deemed to be necessary for market values.

Considered outside the scope of this report is a detailed study of current mobile device technology, such as Android phones, PCs or tablets, as this report does not concentrate on this side of technological developments.

Report Includes:
  • An in-depth analysis of the mobile applications of DNA sequencing, which is a developing personalized healthcare technique with enormous market potential.
  • Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A look at the current and future expectations regarding the cost of individual DNA mapping procedures
  • Quantification of the DNA sequencing markets by product type, indication, and geography
  • Insight into developers of apps, and how DNA mapping and apps combine to produce modern ways of recording information
  • Comprehensive discussion covering DNA sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
  • Patent analysis
  • Company profiles of major players in the DNA sequencing sector, including 23andMe, Helix, Illumina, Thermo Fisher Scientific, and Roche
Note: Product cover images may vary from those shown
2 of 5


  • 23Andme
  • Exploragen
  • Helix
  • Illumina
  • Oxford Nanopore
  • Qiagen
  • MORE
1. Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Geographic Breakdown
Analyst's Credentials
Related Reports

2. Summary and Highlights

3. Overview
DNA Sequencing Techniques
Genome Sequencing/Whole Genome Sequencing
Exome Sequencing/Targeted Sequencing
Earth Microbes
Human Health Microbes
Research into Metagenomics
History of the Development of Epigenomics
DNA Methylation
Histones/Histone Modification
Transcription Start Site
Enhancer Sequences
Enzyme/Chemical Fragmentation of Proteins
Patterned Flow Cells (Illumina)
DNA Polymerase
Polymerase Primers
Heritable Genetic Disorders
Gene Transcription/Translation
Non-Coding RNA (ncRNA)
Cellular Process Regulation
Chromatin Dynamics/Transcription
Gene Splicing
Cell Cycle Progression
DNA Repair
Nuclear Import
Capillary Sequencing
Next Generation Sequencing (NGS)
Molecular Pathology Nodes
Novel Structural Variants (SVs)
Watterson's Estimator
InvFEST Database
Single Molecule, Real-time Sequencing (SMRT)
Zero-Mode Waveguides
Phospholinked Nucleotide
Gene Identification in Genomes
Expression Quantitative Trait Loci (eQTL)
Yeast Strains
Polygenic Diseases
Sequencing Assembly
Structural Variation
Chromosome Inversions
Balanced Translocations
Genomic Imbalances
Long-insert Pair-End Reads (Paired-End Sequencing)
Mate Pair Sequencing
Whole Genome Sequencing
Large Whole Genome Sequencing
Small Whole Genome Sequencing
Trio Analysis
Phased Sequencing/Genome Phasing
Cancer Whole Genome Sequencing (WGS)
Microbial Whole Genome Sequencing
Microbial Whole Genome Resequencing
De Novo Microbial Genome Sequencing
Transcriptome Sequencing
DNA Extraction
Library Preparation
Desktop Sequencing Systems
Alternate Locus
Building Assemblies
Whole Genome Haplotyping
De Novo Sequencing
Antibody De Novo Sequencing
Amplicon Sequencing
Antibody Protein Sequencing of mAbs
Phased Sequencing
Genetic Disorders
Genetic Disorders
Translational Research/Translational Science
CIS/Trans Position
Compound Heterozygotes
De Novo/Microbial Whole Genome Sequencing
De Novo Microbial Genome Sequencing
Microbial Whole Genome Resequencing
Sequencing Method Explorer
Gene Expression Profiling (GEP)
Cell Division
Exon Sequences
Messenger RNAs
Micro RNAs
SNP Arrays
Target-enriched Strategies
In-solution Capture
Microarray Based Genotyping
Sequencing Data Analysis
Genomics Companies

4. Programs, Projects and Developments
Genomics Apps Marketplace
Helix App Store
Genealogy App -- National Geographic's Geno 2.0 Test
23andMe/AncestryDNA -- Rthm -- Sleep App
Recent Developments
SlumberType -- Exploragen
23andMe -- FDA Approval
Genomics Techniques
Shotgun Metagenomics
Genomics Institutes, Programs and Resources
ClinicalTrials.gov (U.S.)
California Initiative to Advance Precision Medicine (CIAPM)
UCSF Clinical Microbiology Laboratory
The National Academy of Sciences (NAS)
Genome.One (Australia)
University of Utah
Biology of Genomes Meeting
Human Genomes Project -- 25th Anniversary
1,000 Genomes Project
National Precision Medicine Research Program
All of Us Research Program
University of Glasgow (Purpose Built Lab)
Scottish Precision Medicine Ecosystem
International HapMap Project
PMI Cohort Program
United Kingdom 300 Million Pounds Human Genome Project
British Society for Genetic Medicine (BSGM)
Genomics England
Medical Research Council Strategic Plan
Efficacy and Mechanism Evaluation Program
NIHR Evaluation, Trials and Studies Coordinating Centre
Health Technology Assessment Program
National Center for Advancing Translational Sciences (NCATS)
CCPM (Colorado Center for Personalized Medicine)
Generalized Genomics
Novel Therapeutics Technology Inc. (NTT)
ISQ EC Single Quadruple Mass Spectrometer (MapPac RM 1MM Columns)
HTG EdgeSeq PATH Assay
Innovator's Edge
Pneumonia Diagnostics Study, U.K. (Inhale Project)
Genetic Diseases Being Researched
CHAPLE Syndrome/Rare Gut Diseases
Trio Analysis
Events in Genomics
Illumina's New Chief Executive -- 2017
Oxford Nanopore Technologies -- Illumina Litigation
AStar Singapore
Specialized Genomic Centers/Related Institutes
Pfizer's Centers for Therapeutic Innovation (CTI)
Rare Diseases Clinical Research Network (RDCRN)
Small Business Innovation Research (SBIR)
Small Business Technology Transfer (STTR)
Therapeutics for Rare and Neglected Diseases (TRND)
Tissue Chip for Drug Screening
Toxicology in the 21st Century (Tox21)
NCATS Center Organization
Centers for Mendelian Genomics (CMG) -- U.K.
National Human Genome Research Institute (NIH) -- U.S.
UCSF Abbot Viral Diagnostic and Discovery Center (VDDC) -- China
DNA Sequencing Devices
SlumberType -- Exploragen
Rthm -- 23andMe
DeepHeart Technology
Personalized Exercise Plans
Sleep Easy
Generalized Genomics
Orphanet Journal of Rare Diseases
Human Phenotype Ontology (HPO)
U.S. National Library of Medicine
PMI Cohort Program

5. Market and Technology Background
DNA Sequencing Technologies
454 Sequencing
PCR (Polymerase Chain Reaction)
Capillary Sequencing
TCGA (The Cancer Genome Atlas) -- DNA Sequencing App
International Cancer Genome Consortium (ICGC)
GA4GH Beacon Project
ISB Cancer Genomics Cloud (ISB-CGC)
Cancer Genome Project
Sequel (BioPac)
Methylation and Uracil Interference Assay Methods
Methylation Interference
Uracil Interference
Copy Number Variations
Whole Exome Sequencing
Fiberoptic Bronchoscopy
Plasmid DNA
Base Pair (BP)
Unnatural Base Pair (UBP)
MSK-Impact Test
Gene Chip
Healthcare Regulations in the U.S.
Precision Medicine
Health Data Compass
Rapid Project (U.K.)
The International Genome Sample Resource (IGSR)
Types of Genetic Tests Available
Genetic Test Register (GTR) -- NIH
Devices Used for DNA Sequencing
Mobile Phone Development
Cellular Mobile Phones
Desktop Personal Computers
Web-based Applications
Mac OS (Mac Operating System)
Windows Mobile
Sales of Mobile Devices
Windows Phone
Windows 10
Computational Biology/Bioinformatics
Mathematical Modeling
Software for Genomics
Pacific Biosciences (PacBio)
NCI Precision Medicine Initiative
Lung Cancer Master Protocol (Lung-MAP)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST)
Molecular Profiling-Based Alignment of Cancer Therapy (NCI-MPACT)
Lung-Map (Lung Cancer Master Protocol)
Exceptional Responders Study (Phenotype to Genotype Trial)
FDA Clearance (510K) Procedures for Medical Devices
Reducing Prices

6. Market Breakdown by Technology Type
NextSeq 500
NextSeq 550
NovaSeq 5000
NovaSeq 6000
HiSeq X Sequencing
Snapshot DNA Phenotyping
NimbleGen Sequencing Capture Microarrays and Services
MasterPure Complete DNA/RNA Purification Kit -- Illumina
Base Space -- Illumina
BaseSpace Correlation Engine
BaseSpace Variant Interpreter
SOLiD Sequencing (Thermo Fisher)
2G, 3G and 4G Android "Smart" Phones
Mobile Apps
Genealogy Apps and Websites
Other Genealogy Companies
Computational Biology/Rare Diseases
Software for Mobile Apps
Computational Biology/Rare Diseases -- Devices
SlumberType App -- Exploragen
NIH (U.S.) Grants for Computational Biology/Bioinformatics
General Genomic Device Information
Forward and Reverse Reads in Paired-End Sequencing -- Device Usage
Patterned Flow Technology -- Illumina
QiaSymphony Platform (CMV Assay)
Catalogue of Somatic Mutations in Cancer (COSMIC)
Membership in the GA4GH
Phenotyping Systems/Platforms

7. Market Breakdown by End Use
National Geographic's Geno 2.0 test
Computational Biology/Rare Diseases
Phased Sequencing
Human Whole Genome Phasing Solutions
Illumina Advanced Long-read Applications Solutions
Illumina Library Kits for Sequencing
Helix App Store
IBM Container Service
IBM BlueMix
API Connect
Cloud Foundry Apps
IoT Platform
Watson Personality Insights
Watson Language Translator
Cloudant NoSQL DB
Watson Tone Analyzer
Watson Conversation
Mobile Push Notifications
BaseSpace -- Illumina
BaseSpace Variant Interpreter for Cancer Samples -- Illumina
ALCHEMIST (Adjuvant Lung Cancer Enrichment Market Identification and Sequencing Trials)
Isaac Whole Genome Sequencing v2 (Illumina)
Male Factor Infertility Genetic Tests
Y Chromosome Microdeletion Test
Cystic Fibrosis Gene Test
Klinefelter Syndrome
Y Chromosome Microdeletion
Chromosome Abnormalities
ISB Cancer Genomics Cloud (ISB-CGC)
Computational Biology/Rare Diseases

8. Market Breakdown by Region
European Society for Medical Oncology (ESMO)
Emerging Markets
Computational Biology/Rare Diseases

9. Patent Review/New Developments
New Developments
Proactive Genetic Health Applications
Beamsplitter/Silicon Photonics
Apache Hadoop
Mobile PGx Platform -- Rennova Health
ThyraMIR Assay
Nanopore Sequencing
Solid State Nanopores -- NGS Sequencing
Hybrid Nanopores
Integrated Sensor Nanopores
Helix App Store

10. Analysis of Market Opportunities
Expanding Market
Next Generation Sequencing (NGS)
Illumina (Solexa) Sequencing
Roche 454 Sequencing
Ion Torrent Proton/PGM Sequencing
All of Us Research Program
Cell Free Fetal DNA Test (cfDNA)
NIPT (Noninvasive Prenatal Testing)
RNA Sequencing -- Next-generation Sequencing (NGS)
Variants -- Prostate Cancers
Liquid Handling Robots/Automation in Genomics
GEP-Based Diagnostic, Prognostic and Predictive Classifiers
Google Cloud Platform
Google App Engine
Google Cloud Datastore
Google Compute Engine
Google Cloud Storage
Google Cloud Pub/Sub
Google Cloud Functions
Google Container Engine
Google Compute Engine
Google Stackdriver
Google BigQuery
Google Cloud Datastore Calls
Syapse Interface
Precision Medicine Data Platform
Social+Capital Partnership
SlumberType App -- Exploragen -- Helix App Store
Thermo Fisher -- YouTube Advertising
DNA Testing Changes
Broad Institute
Helix App Store for DNA Sequencing
Development Opportunities
BioMerieux BacT/Alert Virtuo Receives FDA Clearance
Broad Institute
Invitae/Data Sharing

11. Company Profiles

12. Appendix

List of Tables:
Summary Table: Global Market for Mobile Applications of DNA Sequencing, by End Use, Through 2022
Table 1: Global Market for Mobile Applications of DNA Sequencing in Genealogy, Through 2022
Table 2: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, Through 2022
Table 3: Global Market for Mobile Applications of DNA Sequencing, by Region, Through 2022
Table 4: Global Market Shares of Mobile Applications of DNA Sequencing, by Region, 2022
Table 5: Global Market for Mobile Applications of DNA Sequencing, by End Use, Through 2022
Table 6: Global Market for Mobile Applications of DNA Sequencing for Genealogy, by Region, Through 2022
Table 7: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, by Region, Through 2022
Table 8: Review of Mobile Patents and Patent Applications of DNA Sequencing, 2014-Sept. 2017
Table 9: Abbreviations Used in Mobile Applications of DNA Sequencing
Table 10: Glossary of Terms Used in Mobile Applications of DNA Sequencing
Table 11: Report Sources

List of Figures:
Summary Figure: Global Market for Mobile Applications of DNA Sequencing, by End Use, 2016-2022
Figure 1: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, 2016-2022
Figure 2: Global Market for Mobile Applications of DNA Sequencing, by Region, 2016-2022
Figure 3: Global Market for Mobile Applications of DNA Sequencing, by End Use, 2016-2022
Figure 4: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, by Region, 2016-2022
Note: Product cover images may vary from those shown
3 of 5


4 of 5


  • 23Andme
  • Exploragen
  • Helix
  • Illumina
  • Oxford Nanopore
  • Qiagen
  • MORE
The genomics industry is currently in the early developmental stage and is mostly, aside from genealogy, in the trial, R&D and feasibility study stages. Industry funding is expected to slow over the coming five years, while the economics of this growing industry being applied in global health care services will be a continually growing market.

Reasons for Doing This Study:

This study focuses on mobile applications of DNA sequencing in all currently available platforms and provides current and future market trends.

The application of DNA sequencing will be studied in this report in relation to diagnosing and treating rare diseases, and how genealogy and computational biology are developing to produce market
opportunities. The study aims to evaluate the increasing cost of worldwide healthcare and how mobile applications of DNA sequencing can assist in helping decrease the cost of healthcare worldwide.

The report is aimed at providing information on the growing global awareness of DNA sequencing and DNA mapping and the increasing burden on global healthcare systems. Developers are required to stay up to date with current trends and constantly changing regulations to ensure that global requirements are met, which this study aims to evaluate.

Developers can therefore be guided by the market trends detailed in this report, including the growth or decline in each segment. Market trends across regions and changing attitudes provide information on where the market for DNA sequencing is developing in relation to other regions and countries.

The trends in each region and country indicate where DNA sequencing markets are increasing, allowing this report to be a useful marketing tool. Increasing global awareness of the benefits of DNA sequencing and its future applications and prospects will be studied to show how it will allow for more informed choices in the intended market.

The report offers insights into new technological developments in the mobile device industry and studies future market opportunities for combining mobile applications with developing DNA sequencing
Note: Product cover images may vary from those shown
5 of 5
  • 23Andme
  • Ancestry
  • Exploragen
  • Familysearch
  • Helix
  • Hoffmann-La Roche AG
  • Illumina
  • Myheritage
  • Oxford Nanopore
  • Pacific Biosciences
  • Qiagen
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown